DISCOVER OUR PRODUCTS Classic Liquid or Brand New Powder
Front Endocrinol (Lausanne) 12:645566 Zhang Y et al (2022) Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
GLP-1/Sigma/RAGE receptors: an evolving picture of Alzheimers disease pathology and treatment
(In the past, Siegel received research funds from Vivus, which makes Qsymia, a weight-loss medication that is not a GLP-1 agonist.) GLP-1 agonist medications cause the pancreas to release insulin, which helps control blood sugar, and they slow your gastrointestinal tract down, making you feel full longer and reducing hunger, he explains
Instead of supplying collagen directly, they provide the building blocks your body needs to produce it naturally
Its the hormone these drugs are designed to mimichelping reduce appetite, slow digestion, and regulate blood sugar